Appendix 4C for Q2 2017
July 31, 2017
In accord with ASX requirements, Imagion Biosystems’ quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July, 2017, accompanied by
Tag: MagSense
Imagion Biosystems at BIO 2017
July 14, 2017
The 2017 International Convention of BIO, the Biotechnology Innovation Organization, was held June 19-22 in San Diego. More than 16,000 individuals attended BIO 2017, including
Hear Bob Proulx Interviewed by Health Professional Radio
July 5, 2017
Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on healthcare issues. In
Company Overview Presentation
June 20, 2017
Here are the principal “slide deck” visuals used to introduce Imagion Biosystems to investors prior to the company’s initial public offering on the Australian Securities Exchange. (download
Pre-IPO Investor Conference Call
June 20, 2017
On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on
HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference
June 2, 2017
This year’s Tech Connect World Innovation Conference featured the poster “Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors in mice” presented by Imagion
Detecting Small Tumors
March 10, 2017
Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly. So, to find cancers